Poxel annonce le dmarrage de l’tude de phase 1 du EYP001 par son partenaire ENYO Pharma SA, pour le traitement de l’infection chronique par le virus de l’hpatite B )–Regulatory News: POXEL SA , sociA tA biopharmaceutique dA veloppant des produits innovants pour traiter le diabA te de typ… Poxel Announces Phase 1 Initiation of EYP001 for the Treatment of Chronic Hepatitis B Virus Infection by Licensing Partner ENYO Pharma SA )–POXEL SA , a biopharmaceutical company focused on the development of innovative treatments for type 2 diabetes, announced that ENYO P… )–Kosmos Energy announced today that it has entered into a partnership with BP in Mauritania and Senegal that combines Kosmos’ exploration expertise with … )–Regulatory News: Inside Secure , at the heart of security solutions for mobile and connected devices, today announced that Cat… )–Regulatory News: … (more)